Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
In this webinar, discover how a unified decision intelligence layer across R&D can connect data, understand context, and harness institutional knowledge to enable faster, more confident, and more transparent decision-making.
In this webinar, discover how a unified decision intelligence layer across R&D can connect data, understand context, and harness institutional knowledge to enable faster, more confident, and more transparent decision-making.
In our practical checklist, we walk through the most important criteria to consider when evaluating AI solutions and technology partners, helping you build a future-ready Regulatory strategy.
In our guide, we outline the key considerations life sciences organizations should address when building and scaling an AI strategy in PV.
Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal validation, and help safety teams move from manual review to proactive risk management.
Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal validation, and help safety teams move from manual review to proactive risk management.
Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal validation, and help safety teams move from manual review to proactive risk management.
In our checklist, we outline the most important criteria that leading organizations are keeping in mind when evaluating Agentic AI-powered regulatory intelligence solutions.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved